Delivery Order SPE2DB22D1202-SPE2DB25FVLA0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (30-count) with a ceiling value of $1,322.77. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award under open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 12, 2025, to supply Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) with a firm fixed price ceiling value of $3,789.69. The contract is scheduled for completion by September 15, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a competitively awarded, non-set-aside delivery order with no...
- The Defense Logistics Agency awarded a $1,349.67 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units). This firm fixed-price contract, with a completion date of September 9, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count unit) valued at $1,066.56. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and carries an ultimate completion date of August 29, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $1,064.58 delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) valued at $1,066.56. This non-set-aside competitive award reflects a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count unit) with a ceiling value of $1,599.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is set for ultimate completion by July 31, 2025, and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.92 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit). This is a firm fixed price delivery order with no set-aside designation, issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,619.57 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count packaging), with final delivery due by September 3, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLA0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules in a 90-count package, with a ceiling value of $2,399.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's DLA prime contract enables flexible delivery of a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/11/25 |